With long term unemployment rising in the U.S. and more households under pressure, investors are paying closer attention to how reduced spending might feed through to company revenues and profits. Essential consumer goods stocks can sometimes hold up differently when budgets tighten, but the impact is not uniform. This article looks at how this labor market shock connects to larger food, beverage, and personal care companies, and what that might mean for their risk and resilience. Ahead, you will see 3 stocks from our Consumer Staples screener that appear relatively well positioned against this backdrop.

USANA Health Sciences (USNA)

Overview: USANA Health Sciences develops and sells science based nutritional supplements, meal replacements, and skincare products, targeting everyday wellness needs for adults and children across Asia Pacific, the Americas, and Europe through direct selling, subscriptions, retail, and online channels.

Operations: USANA Health Sciences generates about US$769.0m from Core nutritional products and US$127.0m from Hiya, with smaller segment adjustments, while revenue is spread across China, the United States, other parts of Greater China, North Asia, and the rest of the Americas and Europe.

Market Cap: US$363.4m

USANA Health Sciences sits at an intersection for investors monitoring how long term unemployment and tighter budgets affect everyday spending. The company focuses on nutritional and personal care products that many customers may view as part of ongoing health routines. At the same time, it is working through thin 1% margins, a high P/E, and pressure on active customer numbers. Management is responding with new wellness products such as Glow skincare supplements, digital tools for its direct sales force, and expansion into underpenetrated regions. Some analysts have highlighted the possibility for earnings to change from a low base. Overall, this presents a higher risk, higher potential setup where the details of its direct selling model, geographic exposure, and cash allocation are central to an investor’s thesis.

USANA Health Sciences looks like a classic earnings story where thin 1% margins and a high P/E could be masking an inflection point, so it is worth reading the analyst forecasts for USANA Health Sciences to see what expectations might be missing.

Bega Cheese (ASX:BGA)

Overview: Bega Cheese is an Australian food company that turns raw milk into everyday dairy staples such as cheese, spreads, yoghurts, juices, and milk based drinks, selling through supermarkets, foodservice outlets, petrol stations, and convenience stores, as well as into export markets.

Operations: Bega Cheese generates about A$3.1b from its higher margin Branded products and A$1.1b from Bulk dairy ingredients and nutritionals, offset by A$583.4m of inter segment eliminations.

Market Cap: A$1.8b

Bega Cheese operates in an environment of rising long term unemployment and pressure on household budgets. Consumers often continue to buy core dairy products even when they reduce other spending. The company has a large A$3.1b branded portfolio, is pursuing supply chain efficiency efforts, and has a P/S ratio that sits well below many peers. However, profit margins are thin at 0.2%, past earnings have declined, and funding leans on external borrowing, so execution on restructuring and cost control is important. For investors, it may be useful to weigh those risks against the role of staple dairy demand when deciding whether Bega Cheese warrants further research.

Bega Cheese’s thin 0.2% margins and lower P/S ratio hint at a story the market may not be fully pricing in, so it is worth reading the 1 key reward and 2 important warning signs to see what could shift the balance.

Blackmores (ASX:BKL)

Overview: Blackmores is an Australian headquartered company that sells vitamins, minerals, and nutritional supplements for humans and pets, with products tailored to everyday health, specific conditions, and life stages, distributed through retail and online channels across Australia, New Zealand, Asia, China, and India.

Operations: Blackmores generates about A$293.8m from Australia and New Zealand including the Bioceuticals Group, A$199.1m from international markets, and A$151.0m from China.

Market Cap: A$1.8b

Blackmores may appeal to investors who want exposure to health focused Consumer Staples that tend to sit in regular routines even when unemployment rises and budgets tighten. Margins have improved to 5.4%, and the current P/E is relatively high. The trade off is a balance sheet that relies entirely on external borrowing, a dividend that is not well covered by free cash flow, and a relatively inexperienced board and management team. That mix of growth potential, income, and financial risk makes Blackmores a stock where the detail really matters for long term holders.

Blackmores’ improving 5.4% margins and higher P/E suggest the market is already paying up for its health story, but the real test sits inside the 3 key rewards and 1 important warning sign

The three Consumer Staples stocks covered here are just a starting point, with the full Consumer Staples screener uncovering 42 more companies that pair essential products with equally compelling narratives around resilience, margins, and balance sheets. Use Simply Wall St to identify and analyze the specific catalysts, financial traits, and business stories that matter most so you can focus on the Consumer Staples opportunities that best fit your highest conviction ideas.

Take Control of Your Investment Journey

If Bega Cheese or any of these companies sound like a great opportunity, register for FREE with Simply Wall St and add your companies to a Watchlist to monitor the share price against the fair value the ideal entry point. Once you've made your move, manage your holdings with our Portfolio Command Center that filters out the noise to deliver only the most critical, actionable updates. Throughout your journey, our Community allows you to filter the best ideas from thousands of investor perspectives. By uncovering hidden catalysts and risks early, you'll accelerate your decision-making and stay one step ahead of the market.

Seeking Fresh Alternatives Beyond Consumer Staples?

New ideas can move from quiet to breakout quickly, and by the time momentum is flying, the ideal entry can be caught dropping. Scan these fresh lists and consider your options.

• Spot established income plays before yields get compressed by latecomers by reviewing the curated list of 8 dividend fortresses while the best payouts are still under the radar.
• Review companies in the 29 robotics and automation stocks to explore the next leg of automation momentum as industrial demand and AI spending evolve.
• Explore infrastructure-related opportunities by scanning the hand picked 35 power grid technology and infrastructure stocks while it still reflects stories that many investors may not have fully evaluated yet.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.